About Octant Bio
Next-generation small molecule therapeutics. Drugging the cellular mechanisms that cause disease
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Undisclosed
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
octant.bio
Domain Registered Date
Jun 5, 2017
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Series-B+ announced
fundraisingfox.com
- Capital Raise
Raised $30,000,000 · Series-A
startupintros.com
- Capital Raise
Raised $5,000,000 · Seed
startupintros.com
- Milestone
X account created (@OctantBio)
4.0K followers
- Milestone
Website domain registered
octant.bio
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Octant Bio.
Funding History
Series-B+
· Oct 23, 2025
Undisclosed fundraisingfox.com
Series-A
· May 1, 2020
$30,000,000 startupintros.com
Seed
· Oct 1, 2017
$5,000,000 startupintros.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026